MeSH tree: N06.850
Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides durable clinical benefit ...
Sep 15, 2026
0
6
Chile has become the first country in South America to eliminate dog-transmitted rabies to humans, following more than five decades of public health "prevention and surveillance," the World Health Organization said Monday.
Sep 15, 2026
0
4
Unusually warm periods may be linked to an increased risk of intimate partner violence against women, according to a new IIASA-led study covering 31 countries in sub-Saharan Africa. The findings highlight how rising temperatures ...
Sep 14, 2026
0
8
New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, shows that among people living with type 1 or type 2 diabetes, data from continuous ...
Sep 14, 2026
0
293
Cardiovascular diseases now account for a third of deaths in adults over 40 in a rural South African population.
Sep 14, 2026
0
6
Adding zipalertinib to platinum-pemetrexed chemotherapy significantly improved progression-free survival in patients receiving first-line treatment for advanced non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion ...
Sep 13, 2026
0
7
First-line treatment with trastuzumab deruxtecan (T-DXd) significantly improved progression-free survival compared with pembrolizumab plus platinum-based chemotherapy in patients with advanced or metastatic HER2-mutant non-small ...
Sep 13, 2026
0
3
An exploratory 8-year landmark update from the Phase III ADAURA trial showed that adjuvant osimertinib continued to provide a long-term overall survival benefit for patients with completely resected, EGFR-mutated stage IB–IIIA ...
Sep 13, 2026
0
4
Sacituzumab govitecan (SG) plus pembrolizumab did not demonstrate a statistically significant improvement in progression-free survival compared with pembrolizumab alone as first-line treatment for patients with metastatic ...
Sep 12, 2026
0
10
The phase 3 TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate, significantly improved overall survival, progression-free survival and objective response rate compared ...
Sep 12, 2026
0
5
